AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metauk 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Auk Lifecare Pvt Ltd

Salt Composition

Metformin (1000mg)

Overview Metauk 1000mg Tablet SR

Metformin 1000mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, mitigating associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, consume Metformin 1000mg ER with food, consistently at the same time daily. Discontinue use only under physician guidance. Maintaining a healthy lifestyle, including prescribed diet and exercise, is crucial for effective diabetes management alongside this medication. Common side effects may include diarrhea, nausea, vomiting, gas, fatigue, indigestion, abdominal discomfort, headache, and decreased appetite. Hypoglycemia (low blood sugar) is possible, particularly when combined with other diabetes medications, alcohol, or missed meals; regular blood glucose monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function will be assessed before prescription. Limit alcohol consumption to reduce the likelihood of adverse effects.

Uses of Metauk 1000mg Tablet SR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metauk 1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Metauk 1000mg Tablet SR should be administered with a meal.

Common Side effects of Metauk 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metauk 1000mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metauk 1000mg Tablet SR should be administered with a meal.

How Metauk 1000mg Tablet SR works:

Metformin 1000mg extended-release tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metauk 1000mg Tablet SR and alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metauk 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Metauk 1000mg tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metauk 1000mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metauk 1000mg SR tablets are contraindicated for individuals with severely compromised kidney function.

LiverLiverUNSAFE

The extended-release Metauk 1000mg tablet is contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Metauk 1000mg Tablet SR :

Should you forget to take a Metauk 1000mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Metauk 1000mg Tablet SR

LabelValue
Type of Compound Guanidine-based hypoglycemic agent
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Metauk 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. This results in elevated blood glucose concentrations. Metauk 1000mg Tablet SR employs a multi-faceted approach to lower these elevated blood sugar levels. The medication reduces hepatic glucose production, diminishes intestinal glucose absorption post-prandially, and enhances insulin sensitivity in peripheral tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metauk 1000mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals with pre-diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience similar results. However, self-prescribing this medication for weight management is strongly discouraged; physician consultation is essential.
Metformin 1000mg extended-release tablets are frequently an initial treatment for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and diminishing intestinal glucose absorption. In contrast to other oral hypoglycemics, Metformin 1000mg extended-release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism of action which avoids excess insulin secretion. Beyond glycemic control, it also aids in weight management.
Metauk 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Metauk 1000mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Consult your physician if fatigue or sleepiness develops during Metauk 1000mg sustained-release tablet use.
Administer Metauk 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast, the other with dinner. For three daily doses, distribute them with breakfast, lunch, and dinner. Consuming Metauk 1000mg SR tablets with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's insulin. This results in elevated blood glucose levels. Metauk 1000mg Tablet SR addresses this hyperglycemia through multiple mechanisms. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in peripheral tissues. These actions facilitate improved glucose uptake from the bloodstream and augment the body's natural insulin response.
Individuals overweight or obese have experienced weight reduction while taking Metauk 1000mg Tablet SR. This medication may also modestly reduce weight in overweight or obese individuals predisposed to diabetes. Furthermore, weight loss has been observed in patients with insulin sensitivity or resistance. However, self-prescribing Metauk 1000mg Tablet SR for weight loss is strongly discouraged; physician consultation is essential.
Metformin 1000mg extended-release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike other oral hypoglycemics, Metformin 1000mg extended-release tablets, when used monotherapy, infrequently lead to hypoglycemia because they don't stimulate excessive insulin release. Beyond glycemic control, this medication also aids in weight management.
Metauk 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Metauk 1000mg sustained-release tablets may lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Seek medical attention if fatigue or sleepiness develops during Metauk 1000mg sustained-release tablet treatment.
Administer Metauk 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, take the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metauk 1000mg SR tablets with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose concentrations. Metauk 1000mg Tablet SR employs multiple mechanisms to lower these elevated blood sugar levels. Specifically, it reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues and organs. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metauk 1000mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-medicating with this drug for weight management is inadvisable; physician consultation is essential.
Metauk 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing insulin responsiveness, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, solo administration of Metauk 1000mg Tablet SR infrequently results in hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, this medication also aids in weight management.
Metauk 1000mg extended-release tablets typically do not induce drowsiness and are generally well-received. Infrequently, however, Metauk 1000mg extended-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Seek medical advice if fatigue or sleepiness develops during Metauk 1000mg extended-release tablet use.
Administer Metauk 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily regimens, consume the tablet with breakfast. Twice-daily prescriptions should be divided, one with breakfast and the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metauk 1000mg sustained-release tablets with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metauk 1000mg Tablet SR
30
MRP 35
14% off